Canine Hemangiosarcoma Cell Lines In Vitro Platform Captures Morphological, Functional, and Molecular Diversity.
4 affiliations
- 1IRET Foundation ETS, Ozzano Emilia, 40064 Bologna, Italy.
- 2Health Science and Technologies Interdepartmental Center for Industrial Research (HST-ICIR), University of Bologna, 40064 Bologna, Italy.
- 3Department of Veterinary Medical Sciences, University of Bologna, 40064 Bologna, Italy.
- 4Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Abstract
Both canine hemangiosarcoma and human angiosarcoma are aggressive malignancies characterized by clinical and molecular heterogeneity. Current in vitro models rely on individual cell lines, failing to capture this biological complexity. We established a standardized 2D in vitro platform comprising a panel of three canine primary splenic hemangiosarcoma cell lines (EMN009, EMN011, EMN017) and one patient-matched brain metastasis (EMN010) evaluated in parallel. Using gold-standard assays-morphometrics, growth, migration and tube-formation assays-alongside disease-relevant transcriptomic and microRNA profiling, we characterized this multi-line system under harmonized conditions. Neoplastic lines shared a robust core angiogenic signature of 42 overexpressed genes linked to VEGF, AGE-RAGE, and S1P signaling, and a 47-gene cancer stem cell engine enriched in the Hippo/YAP1 pathway. Transcriptomic clustering divided the lines into slower-growing primary tumors (EMN009/EMN011) and highly angiogenic phenotypes (EMN017/EMN010). Isogenic comparison revealed that the metastatic EMN010 uniquely upregulates STAT signaling and peptidyl-tyrosine phosphorylation. MicroRNA profiling demonstrated a global downregulation of tumor-suppressors miR-126-5p and miR-452-5p, unleashing VEGFA-driven angiogenesis, while visceral hemangiosarcoma biomarker miR-214-3p was significantly upregulated. Conversely, miR-10b and miR-133-3p expression varied across lines, reflecting ongoing clonal evolution. This integrated platform successfully recapitulates hemangiosarcoma heterogeneity, providing a reliable, standardized framework for comparative oncology and targeted pathophysiological studies.
Related
- "Morphological, Functional, and Molecular Progression of Blood-Brain Barrier Dysfunction in Alzheimer's Disease".
- Defining functional puberty in female C57BL/6J mice using endocrine, cytological and morphological markers
- Switching to Faricimab in Patients with Chronic Diabetic Macular Edema Refractory to Previous Anti-VEGF Therapy: Morphological and Functional Outcomes Including Optical Coherence Tomography Angiography Parameters
- Nutritional and bioactive diversity of mangrove fruits: a comparative perspective for functional food development
- First molecular and morphological characterization of Entamoeba bovis in domestic and wild ruminants in Italy reveals a shared lineage across host species and ecological settings
BibTeX
@article{caporiacco2026canine,
title = {{Canine Hemangiosarcoma Cell Lines In Vitro Platform Captures Morphological, Functional, and Molecular Diversity.}},
author = {Lucia di Caporiacco and Francesca Merighi and Luciana Giardino and Laura Marconato and Vito Antonio Baldassarro and Laura Calzà and Corinne Quadalti},
journal = {Animals : an open access journal from MDPI},
year = {2026},
month = oct,
doi = {10.3390/ani16193109},
url = {https://europepmc.org/article/MED/42883078},
note = {CC BY},
}
RIS
TY - JOUR
TI - Canine Hemangiosarcoma Cell Lines In Vitro Platform Captures Morphological, Functional, and Molecular Diversity.
AU - Lucia di Caporiacco
AU - Francesca Merighi
AU - Luciana Giardino
AU - Laura Marconato
AU - Vito Antonio Baldassarro
AU - Laura Calzà
AU - Corinne Quadalti
PY - 2026
DA - 2026/10/03
JO - Animals : an open access journal from MDPI
DO - 10.3390/ani16193109
UR - https://europepmc.org/article/MED/42883078
AB - Both canine hemangiosarcoma and human angiosarcoma are aggressive malignancies characterized by clinical and molecular heterogeneity. Current in vitro models rely on individual cell lines, failing to capture this biological complexity. We established a standardized 2D in vitro platform comprising a panel of three canine primary splenic hemangiosarcoma cell lines (EMN009, EMN011, EMN017) and one patient-matched brain metastasis (EMN010) evaluated in parallel. Using gold-standard assays-morphometrics, growth, migration and tube-formation assays-alongside disease-relevant transcriptomic and microRNA profiling, we characterized this multi-line system under harmonized conditions. Neoplastic lines shared a robust core angiogenic signature of 42 overexpressed genes linked to VEGF, AGE-RAGE, and S1P signaling, and a 47-gene cancer stem cell engine enriched in the Hippo/YAP1 pathway. Transcriptomic clustering divided the lines into slower-growing primary tumors (EMN009/EMN011) and highly angiogenic phenotypes (EMN017/EMN010). Isogenic comparison revealed that the metastatic EMN010 uniquely upregulates STAT signaling and peptidyl-tyrosine phosphorylation. MicroRNA profiling demonstrated a global downregulation of tumor-suppressors miR-126-5p and miR-452-5p, unleashing VEGFA-driven angiogenesis, while visceral hemangiosarcoma biomarker miR-214-3p was significantly upregulated. Conversely, miR-10b and miR-133-3p expression varied across lines, reflecting ongoing clonal evolution. This integrated platform successfully recapitulates hemangiosarcoma heterogeneity, providing a reliable, standardized framework for comparative oncology and targeted pathophysiological studies.
SN - 2076-2615
ER -